Cargando…
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis
Docetaxel resistance developed in half of castration-resistant prostate cancer (CRPC) patients hinders its long-term clinical application. The current study was designed to investigate the effects of Chinese medicine Zhoushi Qi Ling decoction on the docetaxel resistance of prostate cancer as well as...
Autores principales: | Cao, Hongwen, Wang, Dan, Sun, Peng, Chen, Lei, Feng, Yigeng, Gao, Renjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544336/ https://www.ncbi.nlm.nih.gov/pubmed/34613933 http://dx.doi.org/10.18632/aging.203602 |
Ejemplares similares
-
Qi Ling decoction enhances abiraterone treatment via suppression of autophagy in castration resistant prostate cancer
por: Feng, Yigeng, et al.
Publicado: (2022) -
QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo
por: Cao, Hongwen, et al.
Publicado: (2023) -
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
por: Cao, Hongwen, et al.
Publicado: (2022) -
Qi Ling decreases paclitaxel resistance in the human prostate cancer by reversing tumor-associated macrophages function
por: Cao, Hongwen, et al.
Publicado: (2022) -
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway
por: Cao, Hongwen, et al.
Publicado: (2023)